ReviewApplied biochemistry and biotechnology2026
Green Nanomedicine from Eupatorium: Phytochemical-Driven Synthesis of Therapeutic Nanoparticles for Biomedical Applications.
Review in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The review discusses the evolution of the genus Eupatorium from a traditional herbal medicine to a significant drug in green sustainable nanomedicine, addressing to the demand for focused scientific bridge between its phytochemistry and nanotechnology. The synthesis of Eupatorium-mediated nanoparticles is determined by secondary metabolites, specifically flavonoids such as eupafolin, as well as phenolic acids and terpenoids. The hydroxyl (-OH) and carbonyl (C = O) functional groups of these compounds contribute to the bioconjugation of metal ions that turn into valuable nanoparticles, while they also act as capping agents to prevent aggregation, typically producing particles on the scale of 10-100 nm. Quantitative data evidence showed enhanced effectiveness of these nano formulations compared to crude extracts; antimicrobial zones of inhibition reaching 9-20 mm against pathogens such as E. coli and S. aureus, additionally antiviral efficacy against clinical viruses induced by E. perfoliatum have been reported in the range 59.59% to 72.78% .In addition, specific compounds such as eupalinolide demonstrate potent cytotoxicity with IC
Indexed as
Identifiers
42268343What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.